Abstract:The successful implementation of stem cell therapy requires the development of imaging techniques to track transplanted stem cells in vivo and monitor their fate over time. Most in vivo imaging methods focus on providing information about the distribution and migration of transplanted stem cells, while monitoring their viability-crucial for optimizing therapy-remains undeveloped. Although a few in vivo imaging techniques have been developed for assessing the viability of transplanted stem cells, their applicability is restricted by limited penetration depth. To address this, magnetic resonance imaging (MRI) that is collaboratively utilized with tailored contrast agents has been explored to track the viability of transplanted stem cells without this limitation. However, currently available MRI contrast agents struggle with low accuracy in monitoring viability due to poor controllability or minimal signal change in response to cell death. Here, we present an extremely small iron oxide nanoparticles (ESIONPs)-based T1-T2 switchable MRI contrast agent (ESIONPs-GSH) designed to accurately detect cell apoptosis in response to elevated reactive oxygen species (ROS).Specifically, ESIONPs-GSH was obtained by modifying the surface of ESIONPs with ROS-sensitive glutathione (GSH) and amphipathic 3-((3-aminopropyl) dimethylammonio) propane-1-sulfonate (ADPS) molecules. The results demonstrate that ESIONPs-GSH is biocompatible, with negligible effects on the proliferation and differentiation of bone mesenchymal stem cells (BMSCs) post-labeling. Additionally, BMSCs labeled with ESIONPs-GSH exhibit T1 contrast; upon cell death, increasing cellular ROS oxidize GSH and induce cross-linking of ESIONPs-GSH, resulting in a switch to T2 contrast. Benefiting from the significantly contrasting signal following the T1-T2 contrast switch, ESIONPs-GSH allows for accurate assessment of the survival of BMSCs transplanted into the axillary regions of mice through MRI monitoring. ESIONPs-GSH enabled MRI can effectively track transplanted stem cell viability in vivo without penetration depth limitations, making it a promising tool for guiding stem cell-based therapies.

In Vivo Tracking of the Tropism of Mesenchymal Stem Cells to Malignant Gliomas Using Reporter Gene-Based MR Imaging

Migration and localization of bone marrow mesenchymal stem cells labeled by DAPI in the brain of glioma rat models

In Vivo Tracking of Superparamagnetic Iron Oxide Nanoparticle-Labeled Mesenchymal Stem Cell Tropism to Malignant Gliomas Using Magnetic Resonance Imaging. Laboratory Investigation.

Quantification of the Engraftment Status of Mesenchymal Stem Cells in Glioma Using Dual-Modality Magnetic Resonance Imaging and Bioluminescence Imaging

Stem Cell Labeling With Superparamagnetic Iron Oxide Nanoparticles Using Focused Ultrasound And Magnetic Resonance Imaging Tracking

Mesenchymal Stem Cells As Therapeutic Agents and in Gene Delivery for the Treatment of Glioma

In Vivo Long-Term Tracking of Neural Stem Cells Transplanted into an Acute Ischemic Stroke Model with Reporter Gene-Based Bimodal MR and Optical Imaging

Human Menstrual Blood-Derived Mesenchymal Stem Cells As a Cellular Vehicle for Malignant Glioma Gene Therapy

MRI Tracking of SPIO- and Fth1-Labeled Bone Marrow Mesenchymal Stromal Cell Transplantation for Treatment of Stroke

Peritumoral administration of IFN upregulated mesenchymal stem cells inhibits tumor growth in an orthotopic, immunocompetent rat glioma model

In Vivo Tracing of Transplanted Bone Marrow Mesenchymal Stem Cells with Bioluminescence Imaging

Molecular Imaging for Assessment of Mesenchymal Stem Cells Mediated Breast Cancer Therapy.

Tracking mesenchymal stem cells using magnetic resonance imaging

In Vivo MR Imaging Tracking of Transplanted Mesenchymal Stem Cells in a Rabbit Model of Acute Peripheral Nerve Traction Injury.

Probe-Based Confocal Laser Endomicroscopy for Imaging TRAIL-Expressing Mesenchymal Stem Cells to Monitor Colon Xenograft Tumors In Vivo.

Magnetic resonance and photoacoustic imaging of brain tumor mediated by mesenchymal stem cell labeled with multifunctional nanoparticle introduced via carotid artery injection

Polymeric vector-mediated gene transfection of MSCs for dual bioluminescent and MRI tracking in vivo.

In vivo tracking of implanted stem cells using radio-labeled transferrin scintigraphy

In Vivo MRI Tracking of Bone Mesenchymal Stem Cell Viability with a T1-T2 Switchable Contrast Agent

High MR Sensitive Fluorescent Magnetite Nanocluster for Stem Cell Tracking in Ischemic Mouse Brain.

The Experimental Investigation of Glioma ⁃trophic Capacity of Human Umbilical Cord-Derived Mesenchymal Stem Cells after Intraventricular Administration